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Abstract 
Background: Radiotherapy can cause adverse skin reactions over the course of their treatment. Currently, management is based on 
several tropical products although there is no gold-standard approach to prevention and management of radiation toxicity. 
Method: We report our experience of vitamin E acetate in the treatment of radiation dermatitis in breast cancer patients who experienced 
grade 4 side effects (according to Radiation Therapy Oncology Group criteria).  
Results: Clinical management consisted of oral antibiotics and local application of vitamin E acetate and local escarectomy. All of the 
patients achieved complete re-epithelialization within 40 days.  
Conclusion: Skin ulceration and necrosis post-radiation may interrupt oncological treatment in breast cancer patients. In acute 
radiodermatitis with skin necrosis, we propose the use of oral antibiotics together with escarectomy and the application of vitamin E 
acetate to facilitate the healing process in order to minimize the interruption to the oncological treatment. 
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Background 
The standard treatment for early breast cancer includes 
conserving breast surgery followed by radiation therapy and 
systemic treatment. One of the common side effects of 
irradiation is a skin reaction, including acute erythema, 
desquamation and, rarely, delayed radiodystrophy or 
radionecrosis. Mild to moderate acute dermatitis occurring 
during the treatment course is common. While more severe 
acute injury is rare and normally only occurs in cases with 
specific skin sensibility or to an area receiving a higher dose of 
radiation, it may lead to local infection associated with skin 
ulceration similar to a severe skin burn [1–5]. Severe acute 
dermatitis may require interruption of the radiation therapy and 
oncological treatment course. Local treatment of acute radiation 
dermatitis usually includes corticoid creams [6–8]. We present a 
case of acute dermatitis occurring during a course of 
radiotherapy for conservative treatment of breast cancer. The 
aim of this report is to focus on the local treatment (vitamin E 
acetate in lipophilic gel (named as Vea Oil ®) plus escarectomy 
and oral antibiotic administration. 
 
Method 
Case report:  A 67-year-old women was submitted to 
conservative surgery for a ductal infiltrating carcinoma of the left 
breast, stage pT1c, pN0, M0, G3, ER: 0%; PgR: 0%; Ki-67: 
70%; c-erb B2: absent. Post-operative therapy included 
chemotherapy (CMF - 6 cycles) and external radiotherapy (50 
Gy with an additional boost of 10 Gy in tangential fields with 
photon energy of 6 MV given in 2 Gy daily fractions, 5 
fractions/week). The radiotherapy started after the third cycle of 
chemotherapy, despite the neutropenia. After 40 Gy of 
radiotherapy, the patient presented a skin lesion of the 4° grade 
(criteria of the Radiation Therapy Oncology Group, RTOG) 
erythema, cutaneous necrosis, pain, fever and a 
Staphylococcus aureus infection (Figure 1). The radiation 
treatment plan was reviewed and an overdose area was 
revealed. In this case, local treatment with vitamin E acetate as 
a lipophic gel, escarectomy and oral antibiotics were 
administered. 
 
Result 
This patient was treated with oral antibiotics and local 
application of vitamin E acetate from the first day after the 
presentation of the skin lesion. After six days, an escarectomy 
was performed under local anaesthesia (Figure 2). After 25 
days, the infection had resolved and total re-epithelialization 
was observed (Figure 3). After 40 days, the result was 
excellent. Further patients were treated with the same 
procedure, and in all cases, their skin complications healed 
within 40 days and the same satisfactory results were achieved 
(Figure 4). 
 
Discussion 
Extensive radiation dermatitis usually requires several months 
to heal and often does not heal spontaneously. Some of the 
healed aesthetic results are unsatisfactory and may require 
plastic surgery procedures. In our case, the association of oral 
antibiotics and local treatment with Vea Oil®—vitamin E acetate 
allowed complete healing of the wounds within 40 days.  The 
idea of using the oil alpha-tocopherol acetate for topical skin 
treatment was based on the following evidence: (a) the redox 
chemistry of the vitamin, compatible with an anti-oxidant effect 
in vivo [9,10]; (b) the hydrolysis of the ester in the skin [11] and 
thus the pro-drug nature of the acetate; (c) the prospect of a 
physiological extracellular function of vitamin E, which is, 
indeed, secreted and reabsorbed by the skin [12]. The 
beneficial effect, in relation to the preservation of the barrier 
function of the skin, is clearly evident.  
 
Conclusion 
Skin ulceration and necrosis post-radiation may interrupt 
oncological treatment of the breast cancer patient. In acute 
radiodermatitis with skin necrosis, we propose the use of oral 
antibiotics together with escarectomy and the application of 
vitamin E acetate to facilitate the healing process in order to 
minimize the interruption to the oncological treatment. 
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Figure 1: Erythema associated with flyctena, cutaneous necrosis, pain, fever and staphylococcus aureus infection. 
 
 
Figure 2: After escarectomy in local anaestesia. 
 
 
Figure 3: After 25 days of treatment.
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Figure 4:  After 40 days of treatment.
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